Enzo Biochem (ENZ) Stock Statistics & Valuation Metrics

Enzo Biochem has a market cap or net worth of $16.98M. The enterprise value is $15.61M.

Enzo Biochem has 52.40M shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzo Biochem’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -15.86%.

The current PE Ratio of Enzo Biochem is -2.23. Enzo Biochem’s PEG ratio is 0.04.

In the last 12 months, Enzo Biochem had revenue of $29.09M and earned -$21.31M in profits. Earnings per share was -$0.41.

In the last 12 months, operating cash flow was -$14.96M and capital expenditures -$784.00K, giving a free cash flow of -$15.75M billion.

Enzo Biochem pays an annual dividend of $0.10, resulting in a dividend yield of

Enzo Biochem upcoming earnings date is Jun 16, 2025, After Close.

Enzo Biochem as a current ratio of 2.82, with Debt / Equity ratio of 0.06

In the past 12 months, Enzo Biochem has paid $1.48M in taxes.

Enzo Biochem EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -0.34.

Enzo Biochem has $40.30M in cash and marketable securities with $2.92M in debt, giving a net cash position of -$37.38M billion.

Gross margin is 45.86%, with operating margin of -30.77%, and net profit margin of -81.73%.

The average price target for Enzo Biochem is , which is 11.43% higher than the current price. The consensus rating is